Jurgi Camblong
Founder chez SOPHIA GENETICS SA
Fortune : 12 M $ au 31/03/2024
Profil
Jurgi Camblong is the founder of SOPHiA GENETICS SA, which was founded in 2011.
He is currently the Chairman of Agora Care SA and the Director of Swiss Biotech Association.
Dr. Camblong was the Chief Executive Officer of Gene Predictis SA from 2010 to 2011.
He was also an Associate at the University of Oxford and the University of Geneva.
Dr. Camblong holds an MBA from École Polytechnique Fédérale de Lausanne and a doctorate from the University of Geneva.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
SOPHIA GENETICS SA
3,77% | 15/02/2024 | 2 460 081 ( 3,77% ) | 12 M $ | 31/03/2024 |
Postes actifs de Jurgi Camblong
Sociétés | Poste | Début |
---|---|---|
SOPHIA GENETICS SA | Founder | 01/01/2011 |
Swiss Biotech Association
Swiss Biotech Association Miscellaneous Commercial ServicesCommercial Services Swiss Biotech Association operates as an industry association. The private company is based in Zurich, Switzerland. Michael Altorfer has been the CEO of the Swiss company since 2018. | Director/Board Member | - |
Agora Care SA
Agora Care SA Information Technology ServicesTechnology Services Agora Care SA provides IT services. The Swiss company was founded in 2021 by Joël Spaltenstein. Osman Ratib has been the CEO of the company since 2021. | Chairman | - |
Anciens postes connus de Jurgi Camblong
Sociétés | Poste | Fin |
---|---|---|
GENE PREDICTIS SA
GENE PREDICTIS SA Miscellaneous Commercial ServicesCommercial Services Part of NIMGenetics Genómica y Medicina SL, Gene Predictis SA engages in the development of diagnostic tools based on genetics that allow treatments for patients. The private company is based in Lausanne, Switzerland. The Swiss company was founded in 2004. Goranka Tanackovic has been the CEO of the company since 2011. Gene Predictis was acquired by NIMGenetics Genómica y Medicina SL on February 13, 2023. | Chief Executive Officer | 01/01/2011 |
University of Geneva | Corporate Officer/Principal | - |
University of Oxford | Corporate Officer/Principal | - |
Formation de Jurgi Camblong
École Polytechnique Fédérale de Lausanne | Masters Business Admin |
University of Geneva | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
SOPHIA GENETICS SA | Technology Services |
Entreprise privées | 3 |
---|---|
Swiss Biotech Association
Swiss Biotech Association Miscellaneous Commercial ServicesCommercial Services Swiss Biotech Association operates as an industry association. The private company is based in Zurich, Switzerland. Michael Altorfer has been the CEO of the Swiss company since 2018. | Commercial Services |
GENE PREDICTIS SA
GENE PREDICTIS SA Miscellaneous Commercial ServicesCommercial Services Part of NIMGenetics Genómica y Medicina SL, Gene Predictis SA engages in the development of diagnostic tools based on genetics that allow treatments for patients. The private company is based in Lausanne, Switzerland. The Swiss company was founded in 2004. Goranka Tanackovic has been the CEO of the company since 2011. Gene Predictis was acquired by NIMGenetics Genómica y Medicina SL on February 13, 2023. | Commercial Services |
Agora Care SA
Agora Care SA Information Technology ServicesTechnology Services Agora Care SA provides IT services. The Swiss company was founded in 2021 by Joël Spaltenstein. Osman Ratib has been the CEO of the company since 2021. | Technology Services |